CPMG Inc - Q3 2022 holdings

$510 Million is the total value of CPMG Inc's 4 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .

 Value Shares↓ Weighting
IWB ExitISHARES TRrus 1000 etf$0-2,871
-100.0%
-0.12%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
REATA PHARMACEUTICALS INC23Q2 202376.8%
APOLLO ENDOSURGERY INC22Q1 202315.5%
INVESCO QQQ TR15Q4 20211.4%
FIRST TR NASDAQ-100 TECH IND13Q4 20200.1%
KIRKLAND LAKE GOLD LTD12Q3 20206.5%
INSTIL BIO INC11Q3 202340.7%
TIDEWATER INC NEW11Q4 20201.3%
PROCEPT BIOROBOTICS CORP9Q3 202395.6%
INTUITIVE SURGICAL INC9Q4 201970.1%
UNITED RENTALS INC9Q4 201921.0%

View CPMG Inc's complete holdings history.

Latest significant ownerships (13-D/G)
CPMG Inc Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
REATA PHARMACEUTICALS INCSold outSeptember 28, 202300.0%
Apollo Endosurgery, Inc.Sold outApril 05, 202300.0%
PROCEPT BioRobotics CorpDecember 07, 20225,328,86711.9%
Instil Bio, Inc.April 01, 20218,478,7906.6%
GOLDEN STAR RESOURCES LTD.Sold outFebruary 17, 202100.0%
GENITOPE CORPSold outDecember 12, 200800.0%

View CPMG Inc's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
42023-09-28
SC 13D/A2023-09-28
13F-HR2023-08-14
SC 13D/A2023-08-01
13F-HR2023-05-15
SC 13D/A2023-04-05
42023-04-04
13F-HR2023-02-14

View CPMG Inc's complete filings history.

Compare quarters

Export CPMG Inc's holdings